INFOS !
  • NEW ADDRESS: The management team of ERN-EYE is moving! Starting from March 19, you can find us at 1 Rue Eugène Boeckel, 67000 Strasbourg.

Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

Vamikibart in Participants With Uveitic Macular Edema (Sandcat)

In this page

Clinical Trial

NCT05642325 Active, Not recruiting
Vamikibart in Participants With Uveitic Macular Edema (Sandcat)

A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Vamikibart Administered Intravitreally in Patients With Uveitic Macular Edema Conditions

Phase 3
Interventional

Disease

Disease type

Uveitis

Orphan drug recognition

Yes

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

23/03/2023

Closing date

30/06/2025

Inclusion criteria :

More

Exclusion criteria :

More

Funding

private

ERN EYE member investigating site

HCP : Principal investigators

OPHTARA – Hôpital Pitié-Salpêtrière, Paris, France

Adress

Service d'ophtalmologieBât. Lecourbe - RC149 rue de Sèvres

75 015 Paris

France

Centre for Ophthalmology, University Eye Hospital, Tübingen, Germany

Adress

Department für Augenheilkunde Tübingen Forschungsinstitut für Augenheilkunde Elfriede-Aulhorn-Str. 7

72076 Tübingen

Germany